Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (4)
- Eli Lilly targets booming black market for retatrutide STAT · 5d ago
- Eli Lilly tries to stop GLP-1 copycats Yahoo Finance · 5d ago
- Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide biopharmadive.com · 5d ago
- Lilly Takes On Peptide Industry to Protect Buzzy Obesity Shot Retatrutide Bloomberg.com · 5d ago broke it first
Related trends
Credit card issuer Synchrony partners with OpenAI for ChatGPT shopping
Credit card issuer Synchrony has partnered with OpenAI to bring store cards and shopping offers into ChatGPT.
The Surprising Reason This Biotech Plummeted 69%
EyePoint Pharmaceuticals shares cratered following a late-stage trial setback for its flagship eye disease drug.
China's recovery sputters as consumption, output lose steam
China's economic recovery is losing momentum as retail sales, output, and investment slow down.
Alibaba to Sell Videogame Business for at Least $1.5 Billion
Alibaba moves to sell its videogame business to prioritize artificial intelligence and e-commerce.
Big investors hunt for tomorrow's AI winners as capex angst fades
Major investors are shifting focus toward emerging artificial intelligence opportunities as capital expenditure concerns diminish.
Private credit under strain as troubled loans swell
Private credit faces high stress levels and troubled loans, while industry leaders debate systemic risks.